CH565137A5 - - Google Patents

Info

Publication number
CH565137A5
CH565137A5 CH1155171A CH1155171A CH565137A5 CH 565137 A5 CH565137 A5 CH 565137A5 CH 1155171 A CH1155171 A CH 1155171A CH 1155171 A CH1155171 A CH 1155171A CH 565137 A5 CH565137 A5 CH 565137A5
Authority
CH
Switzerland
Application number
CH1155171A
Original Assignee
Ici Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Ltd filed Critical Ici Ltd
Publication of CH565137A5 publication Critical patent/CH565137A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/36Compounds containing oxirane rings with hydrocarbon radicals, substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CH1155171A 1967-09-07 1968-09-06 CH565137A5 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB40961/67A GB1199632A (en) 1967-09-07 1967-09-07 Alkanolamine Derivatives

Publications (1)

Publication Number Publication Date
CH565137A5 true CH565137A5 (xx) 1975-08-15

Family

ID=10417463

Family Applications (2)

Application Number Title Priority Date Filing Date
CH1155171A CH565137A5 (xx) 1967-09-07 1968-09-06
CH1155071A CH553156A (de) 1967-09-07 1968-09-06 Verfahren zur herstellung von alkanolaminderivaten.

Family Applications After (1)

Application Number Title Priority Date Filing Date
CH1155071A CH553156A (de) 1967-09-07 1968-09-06 Verfahren zur herstellung von alkanolaminderivaten.

Country Status (17)

Country Link
US (1) US3634511A (xx)
JP (1) JPS5212182B1 (xx)
AT (3) AT289765B (xx)
BE (1) BE720544A (xx)
CA (1) CA921917A (xx)
CH (2) CH565137A5 (xx)
CS (1) CS152306B2 (xx)
DE (1) DE1793358A1 (xx)
ES (1) ES357931A2 (xx)
FR (1) FR327F (xx)
GB (1) GB1199632A (xx)
IE (1) IE32287B1 (xx)
IL (1) IL30643A (xx)
NL (1) NL6812681A (xx)
NO (1) NO122074B (xx)
SE (1) SE353318B (xx)
SU (1) SU363241A3 (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4146558A (en) * 1966-05-23 1979-03-27 Sterling Drug Inc. Azo dyestuff intermediate nitro- or aminobenzenes ring-substituted by a quaternized amine alkyl or amino-alkoxy group
ES373606A1 (es) * 1968-11-18 1972-06-01 Pfizer Un procedimiento para la preparacion de nuevos derivados depropanolamina.
US3959486A (en) * 1970-05-27 1976-05-25 Imperial Chemical Industries Limited Method for producing β-adrenergic blockage with alkanolamine derivatives
US4059622A (en) * 1970-05-27 1977-11-22 Imperial Chemical Industries Limited Alkanolamine derivatives
US4206144A (en) * 1971-11-22 1980-06-03 Sterling Drug Inc. N,N-Dialkyl-N-aminoalkyl-N-(amino or nitro)phenylalkyl- and N-methyl-N-[3-(amino or nitro)phenoxy-2-hydroxy-1-propyl]-N,N-bis(3-aminopropyl)quaternary ammonium salts
US3919424A (en) * 1972-02-16 1975-11-11 Mead Johnson & Co Bronchodilator process and composition
US3864398A (en) * 1972-05-01 1975-02-04 Teikoku Hormone Mfg Co Ltd Process for the preparation of acylamino alkanol derivatives
JPS5323826B2 (xx) * 1972-05-15 1978-07-17
US4038414A (en) * 1972-06-08 1977-07-26 Ciba-Geigy Corporation Amines and processes for their manufacture
US3993776A (en) * 1973-10-15 1976-11-23 Mead Johnson & Company Anorexigenic process and composition
US3911007A (en) * 1974-08-08 1975-10-07 Searle & Co N-substituted N-benzyloxy-2-methyl-2-(4-halophenoxy)propionamides
MX158644A (es) * 1982-07-20 1989-02-21 Menarini Sas Procedimiento para preparar un derivado 1-alquilamina-3-(4(p-alquiloxibenzamida)-fenoxi)-2propanol
FI832377A0 (fi) * 1983-06-29 1983-06-29 Star Oy Ab Nytt foerfarande foer framstaellning av (r)-, (s)-eller (r,s)-1-(4'-alkylamido-2'-acetyl) fenoxi-3-alkylamino-2-propanoler
US5541204A (en) * 1994-12-02 1996-07-30 Bristol-Myers Squibb Company Aryloxypropanolamine β 3 adrenergic agonists
UY24949A1 (es) * 1997-04-08 2001-04-30 Smithkline Beecham Corp Compuestos calcilíticos

Also Published As

Publication number Publication date
AT289765B (de) 1971-05-10
NL6812681A (xx) 1969-03-11
GB1199632A (en) 1970-07-22
BE720544A (xx) 1969-03-06
US3634511A (en) 1972-01-11
IL30643A0 (en) 1968-10-24
FR327F (xx) 1970-09-21
CS152306B2 (xx) 1973-12-19
JPS5212182B1 (xx) 1977-04-05
SU363241A3 (xx) 1972-12-30
ES357931A2 (es) 1970-04-01
CH553156A (de) 1974-08-30
IE32287B1 (en) 1973-06-13
CA921917A (en) 1973-02-27
DE1793358A1 (de) 1972-11-09
AT291969B (de) 1971-08-10
NO122074B (xx) 1971-05-18
SE353318B (xx) 1973-01-29
IL30643A (en) 1973-01-30
IE32287L (en) 1969-03-07
AT290502B (de) 1971-06-11

Similar Documents

Publication Publication Date Title
AU425114B2 (xx)
FR327F (xx)
AU416737B2 (xx)
AU342066A (xx)
AU2977667A (xx)
AU3189468A (xx)
AU610966A (xx)
AU3151267A (xx)
AU2454867A (xx)
AU2528767A (xx)
BE711575A (xx)
BE426053A (xx)
AU459699A (xx)
BE509738A (xx)
BE483855A (xx)
BE514578A (xx)
BE609869A (xx)
BE609934A (xx)
BE692332A (xx)
AU408412B2 (xx)
AU34866A (xx)
BE477645A (xx)
BE711572A (xx)
BE711444A (xx)
BE711605A (xx)

Legal Events

Date Code Title Description
PL Patent ceased